Thomas Andrew Crockett, CEO: KalVista Pharmaceuticals KALV Sell · Filed 23/02/23

Trade details

Type: Insider sale
Amount: $51,322
Shares · price: 6,700 sh · $7.66 a share
Held after: 120,927 sh
Stock: KalVista Pharmaceuticals KALV
Person: Thomas Andrew CrockettCEO
Trade date: 23/02/17
Filed: 23/02/23
Days to filing: 6 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/18~23/03/19

Thomas Andrew Crockett's recent trades

Thomas Andrew CrockettCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$351.2K
24,888 sh
$351.2K
Filed 24/02/21
Traded 24/02/20
Thomas Andrew CrockettCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$875.9K
58,356 sh
$875.9K
Filed 24/02/16
Traded 24/02/14
Thomas Andrew CrockettCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$150.5K
9,300 sh
$150.5K
Filed 24/02/05
Traded 24/02/01
Thomas Andrew CrockettCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$11.8K
700 sh
$11.8K
Filed 24/02/05
Traded 24/02/01
Thomas Andrew CrockettCEO
Sell10b5-1 planKalVista Pharmaceuticals
Sell10b5-1 plan
KalVista Pharmaceuticals
KALV
$360.6K
30,000 sh
$360.6K
Filed 23/12/28
Traded 23/12/27